By Dr. Shubhang Aggarwal In India, 20 percent people of 16-34 age group are treated for back and neck conditions in India. The percentage of young population going for back…
Latest News
-
-
Uncategorized
Glenmark completes Favipiravir (FabiFlu®) after-marketing surveillance in 1000+ COVID-19 patients
Glenmark Pharmaceuticals has announced today the successful conclusion of its Favipiravir (FabiFlu®) post marketing surveillance (PMS) in India study, which has been carried out under the research of a globally…
-
Mumbai: BDR Pharma, a generic company, announces that Cabozantinib can be launched, which can treat metastatic meduller thyroid, advanced renal cell carcinoma and carcinoma of the hepatocellular cell. Cabozantinib is…
-
Washington: The latest Delta-powered coronaviral wave in the US could soon peak, but experts warn against self-indulgence and expect that the virus will become a part of daily life in…
-
New Delhi: New Delhi On Tuesday 14 September 2021, Niti Aayog Member, V.K. Paul, said that a positive decision could take place before the end of September on the much-awaited…
-
Another NEET-related suicide has been reported in Tamil Nadu, the third in the last five days, when 17-year-old student Soundharya T committed himself three days after taking the exam. Soundharya,…